Tuesday, November 12, 2019 8:23:15 AM
Further, SEC trade filings from over the years will prove things that may not go public...right up to "EXACT" trades of transfer of shares that were pointed out last quarter ....again, impossible to have happened unless multiple hedge funds were working together
Now...taken all these events and bringing us to some midlife crisis that will fall upon some, because Apollo Group Management will be tied to some events as subsidiary MidCap Financial listed under IP assets...but if they listen to some here they should just give up those assets...eh? lol
MidCap Funding III ties to MidCap Financial and is managed by Apollo Capital Management, L.P., a subsidiary of Apollo Global Management, LLC, pursuant to an investment management ...
____
Constructs binding to phosphatidylserine and their use in disease treatment
Abstract
Disclosed are new phosphatidylserine binding constructs with surprising combinations of properties, and a range of diagnostic and therapeutic conjugates thereof. The new constructs effectively bind phosphatidylserine targets in disease and enhance their destruction, and can also specifically deliver attached imaging or therapeutic agents to the disease site. Also disclosed are methods of using the new construct compositions, therapeutic conjugates and combinations thereof in tumor vasculature targeting, cancer diagnosis and treatment, and for treating viral infections and other diseases.
Images (28)
Classifications
C07K14/775 Apolipopeptides
View 20 more classifications
US20060228299A1
United States
Download PDF Find Prior Art Similar
Inventor
Philip Thorpe
Troy Luster
Steven King
Current Assignee
MIDCAP FUNDING III LLC
Peregrine Pharmaceuticals Inc University of Texas System
Worldwide applications
2006 WO NZ DK AU ES SI EP US JP CN CA CN SG CN 2007 IL 2012 JP 2014 HK 2015 US HK 2016 US
Application US11/339,392 events
2005-01-24
Priority to US64633305P
2006-01-24
Application filed by Peregrine Pharmaceuticals Inc, University of Texas System
2006-10-12
Publication of US20060228299A1
2015-02-17
Publication of US8956616B2
2015-02-17
Application granted
2019-11-11
Application status is Active
2027-12-10
Adjusted expiration
______
I admit, information overload is what some will see at first sight....but others see a clear, very well designed plan...to hijack the IP and science behind Billions of $$$ of required patents many will require to pay licensing fees
______
Eli Lilly had most recently went public in ways....and is it a coincidence for them just hiring Brownstein Hyatt Farber Schrek just in last 24 hours? I noticed ex Merck now Brownstein "Jerome Murray landed at Brownstein as well just in Dec 17, 2018
____
Nov 11, 2019
Eli Lilly hires Brownstein Hyatt
By THEODORIC MEYER 11/11/2019 02:30 PM EST
Presented by REALTOR®
With David Beavers and Daniel Lippman
NEW BUSINESS: Eli Lilly has added Brownstein Hyatt Farber Schreck to its lineup of Washington lobbying firms. Zach Pfister, Marc Lampkin, Emily Felder, Nadeam Elshami and Brian Wildwill represent the pharmaceutical giant. Elshami is a former chief of staff to House Speaker Nancy Pelosi. Eli Lilly has spent nearly $5.1 million on Washington lobbying so far this year, according to disclosure filings, and also retains
https://www.politico.com/newsletters/politico-influence/2019/11/11/eli-lilly-hires-brownstein-hyatt-782212
____
Many don't know what many don't know
Recent CDMO News
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:50:20 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/16/2024 11:48:19 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/15/2024 08:40:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/12/2024 08:30:04 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:39 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:02:27 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:22 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:01:05 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:54 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 07/11/2024 09:00:45 PM
- Form 144 - Report of proposed sale of securities • Edgar (US Regulatory) • 07/11/2024 12:23:26 AM
- Avid Bioservices Reports Financial Results for Fourth Quarter and Fiscal Year Ended April 30, 2024 • GlobeNewswire Inc. • 07/02/2024 08:05:04 PM
- Avid Bioservices to Report Financial Results for Quarter and Fiscal Year Ended April 30, 2024, After Market Close on July 2, 2024 • GlobeNewswire Inc. • 07/01/2024 11:00:21 AM
- Avid Bioservices Earns Committed Badge from EcoVadis for Sustainability Performance • GlobeNewswire Inc. • 05/23/2024 12:05:46 PM
- Avid Bioservices to Participate at Upcoming Investor Conferences • GlobeNewswire Inc. • 05/07/2024 08:05:11 PM
- Avid Bioservices Reports Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 04/24/2024 09:25:33 PM
- Avid Bioservices Announces Receipt of Deficiency Notice from Nasdaq Regarding Late Form 10-Q • GlobeNewswire Inc. • 03/20/2024 11:00:10 AM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/07/2024 11:30:11 AM
- Avid Bioservices Announces Pricing of Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/07/2024 04:58:48 AM
- Avid Bioservices Announces Proposed Private Placement of Convertible Notes • GlobeNewswire Inc. • 03/06/2024 09:32:07 PM
- Avid Bioservices Announces Certain Preliminary Financial Results for Third Quarter Ended January 31, 2024 • GlobeNewswire Inc. • 03/06/2024 09:31:28 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 03/06/2024 09:30:18 PM
- Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend] • Edgar (US Regulatory) • 01/26/2024 09:57:52 PM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/13/2024 12:34:35 AM
- Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 01/12/2024 12:39:18 AM
Greenlite Ventures Completes Agreement with No Limit Technology • GRNL • Jul 19, 2024 10:00 AM
VAYK Expects Revenue from First Airbnb Property Starting from August • VAYK • Jul 18, 2024 9:00 AM
North Bay Resources Acquires Mt. Vernon Gold Mine, Sierra County, California, with Assays up to 4.8 oz. Au per Ton • NBRI • Jul 18, 2024 9:00 AM
Nightfood Holdings Signs Letter of Intent for All-Stock Acquisition of CarryOutSupplies.com • NGTF • Jul 17, 2024 1:00 PM
Kona Gold Beverages Reaches Out to Largest Debt Holder for Debt Purchase Negotiation • KGKG • Jul 17, 2024 9:00 AM
Avant Technologies Welcomes Back Former CEO with Eye Toward Future Growth and Expansion • AVAI • Jul 17, 2024 8:00 AM